⌘K

Home/Filings/4/0000819050-21-000091

4//SEC Filing

Breton Jose 4

Accession 0000819050-21-000091

CIK 0000819050other

View on SEC.gov Company Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:46 PM ET

Size

5.5 KB

Accession

0000819050-21-000091

Insider Transaction Report

Form 4

Period: 2021-06-14

Brickell Biotech, Inc.BBI

Chief Accounting Officer

Transactions

Award
Stock Option (right to buy)
2021-06-14+85,000→ 85,000 total
Exercise: $0.90From: 2022-06-14Exp: 2031-06-14→ Common Stock (85,000 underlying)

Footnotes (1)

[F1]The stock options will vest 25% on June 14, 2022, and the remainder will vest in equal monthly installments over the following three years.

Documents

1 file

4
wf-form4_162370356799786.xmlPrimary
FORM 4

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1

filerCIK 0001784373

Filing Metadata

Form type: 4
Filed: Jun 13, 8:00 PM ET
Accepted: Jun 14, 4:46 PM ET
Size: 5.5 KB

View on SEC.gov